Chronic exposure to stress hormones promotes transformation and tumorigenicity of 3T3 mouse fibroblasts

References

• Barnes PJ. 1995. Beta-adrenergic receptors and their regulation. Am J Respir Crit Care Med. 152:838–860.
   PubMed Web of Science ®Google Scholar
• Ben-Eliyahu S. 2003. The promotion of tumor metastasis by surgery and stress: Immunological basis and implications for psychoneuroimmunology. Brain Behav Immun. 17 Suppl. 1: S27–S36.
   Google Scholar
• Ben-Eliyahu S, Page GG, Yirmiya R, Shakhar G. 1999. Evidence that stress and surgical interventions promote tumor development by suppressing natural killer cell activity. Int J Cancer. 80:880–888.
   PubMed Web of Science ®Google Scholar
• Caldecott KW. 2008. Single-strand break repair and genetic disease. Nat Rev Genet. 9:619–631.
   PubMed Web of Science ®Google Scholar
• Collins AR. 2004. The comet assay for DNA damage and repair: Principles, applications, and limitations. Mol Biotechnol. 26:249–261.
   PubMed Web of Science ®Google Scholar
• Daly CJ, McGrath JC. 2011. Previously unsuspected widespread cellular and tissue distribution of beta-adrenoceptors and its relevance to drug action. Trends Pharmacol Sci. 32:219–226.
   PubMed Web of Science ®Google Scholar
• Flint MS, Baum A, Chambers WH, Jenkins FJ. 2007. Induction of DNA damage, alteration of DNA repair and transcriptional activation by stress hormones. Psychoneuroendocrinology. 32:470–479.
   Google Scholar
• Fox BH. 1978. Premorbid psychological factors as related to cancer incidence. J Behav Med. 1:45–133.
   PubMedGoogle Scholar
• Fox BH. 1984. Remote life-style causes of cancer. Cancer Detect Prev. 7:21–29.
   PubMedGoogle Scholar
• Fox BH, Goldsmith JR. 1976. Behavioral issues in prevention of cancer. Prev Med. 5:106–121.
   PubMed Web of Science ®Google Scholar
• Garssen B, Goodkin K. 1999. On the role of immunological factors as mediators between psychosocial factors and cancer progression. Psychiatry Res. 85:51–61.
   PubMed Web of Science ®Google Scholar
• Glasner A, Avraham R, Rosenne E, Benish M, Zmora O, Shemer S, Meiboom H, Ben-Eliyahu S. 2010. Improving survival rates in two models of spontaneous post-operative metastasis in mice by combined administration of a β-adrenergic antagonist and a cyclooxygenasae-2 inhibitor. J Immunol. 184:2449–2457.
   PubMed Web of Science ®Google Scholar
• Hanahan D, Weinberg RA. 2011. Hallmarks of cancer: The next generation. Cell. 144:646–674.
   PubMed Web of Science ®Google Scholar
• Hara MR, Kovacs JJ, Whalen EJ, Rajagopal S, Strachan RT, Grant W, Towers AJ, Williams B, Lam CM, Xiao K, Shenoy SK, Gregory SG, Ahn S, Duckett DR, Lefkowitz RJ. 2011. A stress response pathway regulates DNA damage through beta2-adrenoreceptors and beta-arrestin-1. Nature. 477:349–353.
   PubMed Web of Science ®Google Scholar
• Hasegawa H, Saiki I. 2002. Psychosocial stress augments tumor development through beta-adrenergic activation in mice. Jpn J Cancer Res. 93:729–735.
   PubMedGoogle Scholar
• Jiricny J. 2006. The multifaceted mismatch-repair system. Nat Rev Mol Cell Biol. 7:335–346.
   PubMed Web of Science ®Google Scholar
• Landen CNJr, Lin YG, Armaiz Pena GN, Das PD, Arevalo JM, Kamat AA, Han LY, Jennings NB, Spannuth WA, Thaker PH, Lutgendorf SK, Savary CA, Sanguino AM, Lopez-Berestein G, Cole SW, Sood AK. 2007. Neuroendocrine modulation of signal transducer and activator of transcription-3 in ovarian cancer. Cancer Res. 67:10389–10396.
   PubMed Web of Science ®Google Scholar
• Li J, Yan B, Huo Z, Liu Y, Xu J, Sun Y, Liu Y, Liang D, Peng L, Zhang Y, Zhou ZN, Shi J, Cui J, Chen YH. 2010. Beta2- but not beta1-adrenoceptor activation modulates intracellular oxygen availability. J Physiol. 588:2987–2998.
   PubMed Web of Science ®Google Scholar
• Lillberg K, Verkasalo PK, Kaprio J, Teppo L, Helenius H, Koskenvuo M. 2003. Stressful life events and risk of breast cancer in 10,808 women: A cohort study. Am J Epidemiol. 157:415–423.
   PubMed Web of Science ®Google Scholar
• Lindahl T, Barnes DE. 2000. Repair of endogenous DNA damage. Cold Spring Harbor Symp Quant Biol. 65:127–133.
   PubMedGoogle Scholar
• Lutgendorf SK, DeGeest K, Dahmoush L, Farley D, Penedo F, Bender D, Goodheart M, Buekers TE, Mendez L, Krueger G, Clevenger L, Lubaroff DM, Sood AK, Cole SW. 2011. Social isolation is associated with elevated tumor norepinephrine in ovarian carcinoma patients. Brain Behav Immun. 25:250–255.
   PubMed Web of Science ®Google Scholar
• Masur K, Niggemann B, Zanker KS, Entschladen F. 2001. Norepinephrine-induced migration of SW 480 colon carcinoma cells is inhibited by beta-blockers. Cancer Res. 61:2866–2869.
   PubMed Web of Science ®Google Scholar
• Michael YL, Carlson NE, Chlebowski RT, Aickin M, Weihs KL, Ockene JK, Bowen DJ, Ritenbaugh C. 2009. Influence of stressors on breast cancer incidence in the Women's Health Initiative. Health Psychol. 28:137–146.
   PubMed Web of Science ®Google Scholar
• Nilsson MB, Armaiz-Pena G, Takahashi R, Lin YG, Trevino J, Li Y, Jennings N, Arevalo J, Lutgendorf SK, Gallick GE, Sanguino AM, Lopez-Berestein G, Cole SW, Sood AK. 2007. Stress hormones regulate interleukin-6 expression by human ovarian carcinoma cells through a Src-dependent mechanism. J Biol Chem. 282:29919–29926.
   PubMed Web of Science ®Google Scholar
• Palm D, Lang K, Niggemann B, Drell TLIV, Masur K, Zaenker KS, Entschladen F. 2006. The norepinephrine-driven metastasis development of PC-3 human prostate cancer cells in BALB/c nude mice is inhibited by beta-blockers. Int J Cancer. 118:2744–2749.
   PubMed Web of Science ®Google Scholar
• Perez-Sayans M, Somoza-Martin JM, Barros-Angueira F, Diz PG, Gandara Rey JM, Garcia-Garcia A. 2010. Beta-adrenergic receptors in cancer: Therapeutic implications. Oncol Res. 19:45–54.
   PubMed Web of Science ®Google Scholar
• Powe DG, Entschladen F. 2011. Targeted therapies: Using beta-blockers to inhibit breast cancer progression. Nat Rev Clin Oncol. 8:511–512.
   PubMed Web of Science ®Google Scholar
• Reiche EM, Nunes SO, Morimoto HK. 2004. Stress, depression, the immune system, and cancer. Lancet Oncol. 5:617–625.
   PubMed Web of Science ®Google Scholar
• Ross K. 2008. Mapping pathways from stress to cancer progression. J Natl Cancer Inst. 100:914–915 917.
   PubMedGoogle Scholar
• Sheppard JR. 1977. Catecholamine hormone receptor differences identified on 3T3 and simian virus-transformed 3T3 cells. Proc Natl Acad Sci USA. 74:1091–1094.
   PubMed Web of Science ®Google Scholar
• Sheppard JR, Gormus R, Moldow CF. 1977. Catecholamine hormone receptors are reduced on chronic lymphocytic leukaemic lymphocytes. Nature. 269:693–695.
   PubMed Web of Science ®Google Scholar
• Sloan EK, Priceman SJ, Cox BF, Yu S, Pimentel MA, Tangkanangnukul V, Arevalo JMG, Morizono K, Karanikolas BDW, Wu L, Sood AK, Cole SW. 2010. The sympathetic nervous system induces a metastatic switch in primary breast cancer. Cancer Res. 70:7042–4052.
   PubMed Web of Science ®Google Scholar
• Slotkin TA, Zhang J, Dancel R, Garcia SJ, Willis C, Seidler FJ. 2000. Beta-adrenoceptor signaling and its control of cell replication in MDA-MB-231 human breast cancer cells. Breast Cancer Res Treat. 60:153–166.
   PubMed Web of Science ®Google Scholar
• Thaker PH, Han LY, Kamat AA, Arevalo JM, Takahashi R, Lu C, Jennings NB, Armaiz-Pena G, Bankson JA, Ravoori M, Merritt WM, Lin YG, Mangala LS, Kim TJ, Coleman RL, Landen CN, Li Y, Felix E, Sanguino AM, Newman RA, Lloyd M, Gershenson DM, Kundra V, Lopez-Berestein G, Lutgendorf SK, Cole SW, Sood AK. 2006. Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma. Nat Med. 12:939–944.
   PubMed Web of Science ®Google Scholar
• Tilan J, Kitlinska J. 2010. Sympathetic neurotransmitters and tumor angiogenesis – link between stress and cancer progression. J Oncol. 2010:539706.
   PubMedGoogle Scholar
• West SC. 2003. Molecular views of recombination proteins and their control. Nat Rev Mol Cell Biol. 4:435–445.
   PubMed Web of Science ®Google Scholar
• Yang EV, Sood AK, Chen M, Li Y, Eubank TD, Marsh CB, Jewell S, Flavahan NA, Morrison C, Yeh PE, Lemeshow S, Glaser R. 2006. Norepinephrine up-regulates the expression of vascular endothelial growth factor, matrix metalloproteinase (MMP)-2, and MMP-9 in nasopharyngeal carcinoma tumor cells. Cancer Res. 66:10357–10364.
   PubMed Web of Science ®Google Scholar
• Yang EV, Donovan EL, Benson DM, Glaser R. 2008. VEGF is differentially regulated in multiple myeloma-derived cell lines by norepinephrine. Brain Behav Immun. 22:318–323.
   PubMed Web of Science ®Google Scholar